ARCHIVES

Nader Group Backs FDA In controversy Over Drug Testing

This article is from The Cancer Letter archive.

Vol. 03 No. 06 | February 11, 1977

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

November 28, 2008

NCI Cancer Bulletin publicized board’s resignation over liability concerns.

April 16, 2004

Three Venerable Acronyms Fade Away As Cooperative Groups Form “Alliance”

June 17, 2011

In Brief: MSKCC Launches Molecular Oncology, Genomic Center

May 23, 2014

In Brief: Hatch Bill Would Require NDA Sponsors To Pay Fee; IND, Generic Drug NDAs Would Be Exempt

August 22, 1986

Cancer Informatics: NCI Writing Dictionary To Standardize Data Reported In Trials

November 13, 1998